Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

Core Viewpoint - Standard BioTools Inc. is set to report its second quarter 2024 financial results on July 31, 2024, after market close, indicating ongoing operational progress and financial performance tracking [1]. Group 1: Financial Reporting - The company will announce its second quarter 2024 financial results on July 31, 2024, after the market closes [1]. - A conference call and webcast will be hosted by the company's management at 1:30 p.m. PT, 4:30 p.m. ET on the same day to discuss the financial results and operational progress [2]. Group 2: Company Overview - Standard BioTools Inc. (Nasdaq: LAB), formerly known as Fluidigm Corporation, specializes in next-generation technologies that aid biomedical researchers in developing medicines more efficiently [4]. - The company utilizes proprietary mass cytometry and microfluidics technologies to provide reliable insights in health and disease, focusing on translational and clinical research in areas such as oncology, immunology, and immunotherapy [4].